FDA Approves First Interchangeable Biosimilar for Inflammatory Diseases Physician’s Briefing Staff Oct 19, 2021 Physician's Briefing
First Biosimilar Approved for Macular Degeneration, Other Eye Conditions Physician’s Briefing Staff Sep 23, 2021 Physician's Briefing
Precedent Needed for FDA Approval Decisions When Evidence Lacking Physician’s Briefing Staff Sep 21, 2021 Physician's Briefing
Xywav Gets FDA Approval to Treat Rare Sleep Disorder Physician’s Briefing Staff Aug 13, 2021 Products
Enzyme Replacement Therapy Approved for Late-Onset Pompe Disease Physician’s Briefing Staff Aug 10, 2021 Physician's Briefing
REGEN-COV Authorized for Postexposure Prophylaxis in High-Risk Individuals Physician’s Briefing Staff 04 Aug, 2021 Physician's Briefing
Full Approval of Pfizer COVID-19 Vaccine Could Come in September Physician’s Briefing Staff 04 Aug, 2021 Physician's Briefing
Report Questions Benefit of FDA Accelerated Approval Pathway Physician’s Briefing Staff 30 Jul, 2021 Physician's Briefing
FDA Approves First Biosimilar Insulin Product Physician’s Briefing Staff 29 Jul, 2021 Physician's Briefing
Un asesor del comité de la FDA que criticó al nuevo medicamento para el Alzheimer hace declaraciones Dennis Thompson Hola Doctor 29 Jul, 2021 Consumer News in Spanish
FDA Panel Advisor Who Panned New Alzheimer's Drug Speaks Out Dennis Thompson 28 Jul, 2021 Consumer News
Los médicos están divididos sobre el uso de un controversial medicamento nuevo para el Alzheimer Dennis Thompson Hola Doctor 26 Jul, 2021 Consumer News in Spanish
Doctors Divided Over Use of Controversial New Alzheimer's Drug Dennis Thompson 23 Jul, 2021 Consumer News
FDA Head Asks for Investigation Into Alzheimer Disease Drug Approval Physician’s Briefing Staff 12 Jul, 2021 Physician's Briefing
House Committees to Investigate New Alzheimer Disease Drug Approval Physician’s Briefing Staff 01 Jul, 2021 Physician's Briefing
FDA OKs First Oral Blood Thinning Medication for Children Physician’s Briefing Staff 22 Jun, 2021 Products
米FDAがアルツハイマー病治療薬のアデュカヌマブを迅速承認 Physician’s Briefing Staff HealthDay Japan Translation 13 Jun, 2021 Physician's briefing japanese
Three FDA Advisers Quit Over Agency Approval of Aduhelm Physician’s Briefing Staff 11 Jun, 2021 Physician's Briefing
La FDA aprueba un medicamento para el Alzheimer a pesar de las objeciones de un panel de expertos Dennis Thompson Hola Doctor 08 Jun, 2021 Consumer News in Spanish
